Octean Pharma ApS Financials, key figures and credit report
Gross profit -14.2 kDKK FY 2025 -110.9% vs 2024
EBIT -14.2 kDKK FY 2025 -110.9% vs 2024
Net debt - 113.4 kDKK FY 2025 +52.7% vs 2024
Quick ratio 1.0 FY 2025 -0.1 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 629.82 | 571.14 | 187.91 | 130.23 | -14.15 |
| Employee benefit expenses | - 563.28 | - 562.62 | - 160.67 | ||
| EBIT | 53.68 | 8.52 | 27.25 | 130.23 | -14.15 |
| Other financial income | 4.60 | 1.81 | 4.03 | 0.36 | |
| Other financial expenses | -0.69 | -2.13 | -2.23 | -3.10 | |
| Pre-tax profit | 52.99 | 13.12 | 26.92 | 132.02 | -16.89 |
| Income taxes | -10.01 | -2.44 | -8.10 | -29.54 | 1.49 |
| Net earnings | 42.98 | 10.69 | 18.82 | 102.49 | -15.40 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 337.62 | 252.79 | 139.18 | 191.66 | 222.91 |
| Inventories total | 337.62 | 252.79 | 139.18 | 191.66 | 222.91 |
| Current trade debtors | 259.51 | 129.44 | 145.59 | 97.47 | 209.14 |
| Current amounts owed by group member comp. | 251.75 | 46.38 | |||
| Current other receivables | 0.02 | ||||
| Current deferred tax assets | 5.72 | ||||
| Short term receivables total | 259.51 | 381.19 | 191.97 | 97.49 | 214.86 |
| Cash and bank deposits | 400.21 | 219.63 | 408.24 | 846.54 | 650.92 |
| Cash and cash equivalents | 400.21 | 219.63 | 408.24 | 846.54 | 650.92 |
| Balance sheet total (assets) | 997.35 | 853.61 | 739.39 | 1 135.69 | 1 088.69 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | -2.82 | 40.15 | 50.84 | 69.66 | 172.15 |
| Profit of the financial year | 42.98 | 10.69 | 18.82 | 102.49 | -15.40 |
| Shareholders equity total | 90.15 | 100.84 | 119.66 | 222.15 | 206.75 |
| Non-current liabilities total | |||||
| Current trade creditors | 321.43 | 187.31 | 113.51 | 149.04 | 205.84 |
| Current owed to group member | 287.37 | 387.37 | 387.37 | 606.68 | 537.56 |
| Short-term deferred tax liabilities | 11.77 | 1.93 | 5.99 | 27.08 | |
| Other non-interest bearing current liabilities | 286.63 | 176.16 | 112.86 | 130.75 | 138.54 |
| Current liabilities total | 907.19 | 752.77 | 619.73 | 913.55 | 881.94 |
| Balance sheet total (liabilities) | 997.35 | 853.61 | 739.39 | 1 135.69 | 1 088.69 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated